nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—CALM2—semen—acquired immunodeficiency syndrome	0.0569	0.0727	CbGeAlD
Cinchocaine—CALM1—semen—acquired immunodeficiency syndrome	0.0566	0.0724	CbGeAlD
Cinchocaine—SCN10A—nerve—acquired immunodeficiency syndrome	0.0445	0.0568	CbGeAlD
Cinchocaine—CALM2—nerve—acquired immunodeficiency syndrome	0.0274	0.035	CbGeAlD
Cinchocaine—CALM1—nerve—acquired immunodeficiency syndrome	0.0273	0.0349	CbGeAlD
Cinchocaine—CALM2—endothelium—acquired immunodeficiency syndrome	0.0234	0.0298	CbGeAlD
Cinchocaine—CALM1—endothelium—acquired immunodeficiency syndrome	0.0232	0.0297	CbGeAlD
Cinchocaine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.0207	0.0265	CbGeAlD
Cinchocaine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.0206	0.0264	CbGeAlD
Cinchocaine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.0173	0.0221	CbGeAlD
Cinchocaine—CALM3—retina—acquired immunodeficiency syndrome	0.0145	0.0185	CbGeAlD
Cinchocaine—SCN10A—lymphoid tissue—acquired immunodeficiency syndrome	0.0131	0.0167	CbGeAlD
Cinchocaine—SCN10A—blood—acquired immunodeficiency syndrome	0.0123	0.0157	CbGeAlD
Cinchocaine—SCN10A—spinal cord—acquired immunodeficiency syndrome	0.0119	0.0152	CbGeAlD
Cinchocaine—Chloroquine—TNF—acquired immunodeficiency syndrome	0.0118	1	CrCbGaD
Cinchocaine—SCN5A—digestive system—acquired immunodeficiency syndrome	0.0117	0.015	CbGeAlD
Cinchocaine—CALM2—retina—acquired immunodeficiency syndrome	0.0114	0.0145	CbGeAlD
Cinchocaine—CALM1—retina—acquired immunodeficiency syndrome	0.0113	0.0144	CbGeAlD
Cinchocaine—SCN5A—blood—acquired immunodeficiency syndrome	0.0112	0.0143	CbGeAlD
Cinchocaine—SCN10A—lung—acquired immunodeficiency syndrome	0.0108	0.0138	CbGeAlD
Cinchocaine—SCN5A—vagina—acquired immunodeficiency syndrome	0.0104	0.0133	CbGeAlD
Cinchocaine—SCN10A—nervous system—acquired immunodeficiency syndrome	0.01	0.0128	CbGeAlD
Cinchocaine—CALM2—skin of body—acquired immunodeficiency syndrome	0.00997	0.0127	CbGeAlD
Cinchocaine—CALM1—skin of body—acquired immunodeficiency syndrome	0.00992	0.0127	CbGeAlD
Cinchocaine—CALM3—blood—acquired immunodeficiency syndrome	0.00967	0.0124	CbGeAlD
Cinchocaine—SCN10A—central nervous system—acquired immunodeficiency syndrome	0.00963	0.0123	CbGeAlD
Cinchocaine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.00936	0.012	CbGeAlD
Cinchocaine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.00932	0.0119	CbGeAlD
Cinchocaine—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00909	0.0116	CbGeAlD
Cinchocaine—CALM3—vagina—acquired immunodeficiency syndrome	0.00897	0.0115	CbGeAlD
Cinchocaine—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.00875	0.0112	CbGeAlD
Cinchocaine—CALM3—lung—acquired immunodeficiency syndrome	0.00848	0.0108	CbGeAlD
Cinchocaine—BCHE—skin of body—acquired immunodeficiency syndrome	0.00831	0.0106	CbGeAlD
Cinchocaine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.00807	0.0103	CbGeAlD
Cinchocaine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.00804	0.0103	CbGeAlD
Cinchocaine—CALM2—digestive system—acquired immunodeficiency syndrome	0.00797	0.0102	CbGeAlD
Cinchocaine—CALM1—digestive system—acquired immunodeficiency syndrome	0.00794	0.0101	CbGeAlD
Cinchocaine—SCN10A—brain—acquired immunodeficiency syndrome	0.00764	0.00976	CbGeAlD
Cinchocaine—CALM2—blood—acquired immunodeficiency syndrome	0.0076	0.00971	CbGeAlD
Cinchocaine—CALM1—blood—acquired immunodeficiency syndrome	0.00756	0.00966	CbGeAlD
Cinchocaine—SCN10A—lymph node—acquired immunodeficiency syndrome	0.00738	0.00943	CbGeAlD
Cinchocaine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.00735	0.00939	CbGeAlD
Cinchocaine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.00732	0.00935	CbGeAlD
Cinchocaine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.00732	0.00935	CbGeAlD
Cinchocaine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.00729	0.00931	CbGeAlD
Cinchocaine—CALM2—vagina—acquired immunodeficiency syndrome	0.00704	0.009	CbGeAlD
Cinchocaine—CALM1—vagina—acquired immunodeficiency syndrome	0.00701	0.00896	CbGeAlD
Cinchocaine—SCN5A—brain—acquired immunodeficiency syndrome	0.00694	0.00887	CbGeAlD
Cinchocaine—CALM2—lung—acquired immunodeficiency syndrome	0.00666	0.00851	CbGeAlD
Cinchocaine—BCHE—digestive system—acquired immunodeficiency syndrome	0.00665	0.0085	CbGeAlD
Cinchocaine—CALM1—lung—acquired immunodeficiency syndrome	0.00663	0.00847	CbGeAlD
Cinchocaine—BCHE—blood—acquired immunodeficiency syndrome	0.00633	0.00809	CbGeAlD
Cinchocaine—CALM2—nervous system—acquired immunodeficiency syndrome	0.00617	0.00788	CbGeAlD
Cinchocaine—CALM1—nervous system—acquired immunodeficiency syndrome	0.00614	0.00784	CbGeAlD
Cinchocaine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.00613	0.00783	CbGeAlD
Cinchocaine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.0061	0.0078	CbGeAlD
Cinchocaine—CALM3—brain—acquired immunodeficiency syndrome	0.006	0.00767	CbGeAlD
Cinchocaine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.00594	0.00759	CbGeAlD
Cinchocaine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.00591	0.00755	CbGeAlD
Cinchocaine—BCHE—vagina—acquired immunodeficiency syndrome	0.00587	0.0075	CbGeAlD
Cinchocaine—CALM3—lymph node—acquired immunodeficiency syndrome	0.0058	0.00741	CbGeAlD
Cinchocaine—BCHE—lung—acquired immunodeficiency syndrome	0.00555	0.0071	CbGeAlD
Cinchocaine—BCHE—nervous system—acquired immunodeficiency syndrome	0.00514	0.00657	CbGeAlD
Cinchocaine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.00495	0.00633	CbGeAlD
Cinchocaine—CALM2—brain—acquired immunodeficiency syndrome	0.00471	0.00602	CbGeAlD
Cinchocaine—CALM1—brain—acquired immunodeficiency syndrome	0.00469	0.006	CbGeAlD
Cinchocaine—CALM2—lymph node—acquired immunodeficiency syndrome	0.00456	0.00582	CbGeAlD
Cinchocaine—CALM1—lymph node—acquired immunodeficiency syndrome	0.00453	0.00579	CbGeAlD
Cinchocaine—BCHE—brain—acquired immunodeficiency syndrome	0.00393	0.00502	CbGeAlD
Cinchocaine—BCHE—lymph node—acquired immunodeficiency syndrome	0.0038	0.00485	CbGeAlD
Cinchocaine—CALM3—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000465	0.00226	CbGpPWpGaD
Cinchocaine—CALM2—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00045	0.00219	CbGpPWpGaD
Cinchocaine—CALM1—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00045	0.00219	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000446	0.00217	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000431	0.0021	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000431	0.0021	CbGpPWpGaD
Cinchocaine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000428	0.00208	CbGpPWpGaD
Cinchocaine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000428	0.00208	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000414	0.00202	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000401	0.00195	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000401	0.00195	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000399	0.00194	CbGpPWpGaD
Cinchocaine—SCN10A—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000396	0.00193	CbGpPWpGaD
Cinchocaine—CALM3—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000396	0.00193	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000389	0.00189	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000386	0.00188	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000386	0.00188	CbGpPWpGaD
Cinchocaine—CALM2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000383	0.00186	CbGpPWpGaD
Cinchocaine—CALM1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000383	0.00186	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000376	0.00183	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000376	0.00183	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000361	0.00175	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000352	0.00171	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.00035	0.0017	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00035	0.0017	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.00035	0.0017	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000349	0.0017	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000349	0.0017	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000346	0.00168	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000341	0.00166	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000341	0.00166	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000338	0.00165	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000338	0.00165	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000338	0.00165	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000338	0.00165	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CCNT1—acquired immunodeficiency syndrome	0.000336	0.00164	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000335	0.00163	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000335	0.00163	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000325	0.00158	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000325	0.00158	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000316	0.00154	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000315	0.00153	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000306	0.00149	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000306	0.00149	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000304	0.00148	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000304	0.00148	CbGpPWpGaD
Cinchocaine—CALM3—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000294	0.00143	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000293	0.00143	CbGpPWpGaD
Cinchocaine—CALM1—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000285	0.00139	CbGpPWpGaD
Cinchocaine—CALM2—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000285	0.00139	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000284	0.00138	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000284	0.00138	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000283	0.00137	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.00028	0.00136	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000278	0.00135	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000278	0.00135	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000274	0.00133	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000271	0.00132	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000271	0.00132	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000269	0.00131	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000269	0.00131	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000265	0.00129	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000265	0.00129	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—MBL2—acquired immunodeficiency syndrome	0.00026	0.00126	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000252	0.00123	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—MBL2—acquired immunodeficiency syndrome	0.000251	0.00122	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000251	0.00122	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000246	0.0012	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000246	0.0012	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000239	0.00116	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000238	0.00116	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000238	0.00116	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000237	0.00115	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000236	0.00115	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000236	0.00115	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000236	0.00115	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000231	0.00113	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000231	0.00113	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000229	0.00112	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000229	0.00112	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000229	0.00111	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000229	0.00111	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000228	0.00111	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000228	0.00111	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000228	0.00111	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000228	0.00111	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000227	0.00111	CbGpPWpGaD
Cinchocaine—CALM3—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000226	0.0011	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000223	0.00108	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.00022	0.00107	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.00022	0.00107	CbGpPWpGaD
Cinchocaine—CALM3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000219	0.00107	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000219	0.00106	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000219	0.00106	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000216	0.00105	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000216	0.00105	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000213	0.00104	CbGpPWpGaD
Cinchocaine—CALM3—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000212	0.00103	CbGpPWpGaD
Cinchocaine—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000212	0.00103	CbGpPWpGaD
Cinchocaine—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000212	0.00103	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000211	0.00103	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.00021	0.00102	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00102	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000209	0.00102	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000209	0.00102	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000206	0.001	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000206	0.001	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000205	0.001	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000205	0.001	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000204	0.000995	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000204	0.000995	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CCR2—acquired immunodeficiency syndrome	0.000204	0.000991	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000203	0.00099	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000203	0.00099	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000203	0.000986	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000203	0.000986	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000203	0.000986	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000203	0.000986	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000202	0.000985	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000202	0.000985	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000199	0.000967	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	0.000197	0.000958	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000197	0.000958	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000197	0.000958	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000197	0.000958	CbGpPWpGaD
Cinchocaine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000197	0.000958	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000195	0.000949	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000193	0.000941	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000193	0.000937	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.00019	0.000927	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000189	0.000918	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000189	0.000918	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000187	0.00091	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000187	0.00091	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000186	0.000906	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000186	0.000906	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000183	0.000892	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000178	0.000867	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	0.000178	0.000866	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000177	0.000863	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000177	0.000863	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	0.000177	0.00086	CbGpPWpGaD
Cinchocaine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000174	0.000848	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000172	0.000839	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000172	0.000839	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	0.000172	0.000838	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000172	0.000838	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	0.000171	0.000832	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000171	0.000832	CbGpPWpGaD
Cinchocaine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000169	0.000821	CbGpPWpGaD
Cinchocaine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000169	0.000821	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000159	0.000775	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000157	0.000764	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000154	0.00075	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000154	0.00075	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000152	0.000739	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000152	0.000739	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000146	0.000708	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000145	0.000706	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000145	0.000703	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000144	0.000699	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	0.000143	0.000698	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	0.000143	0.000698	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000141	0.000688	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000141	0.000685	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000141	0.000685	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	0.00014	0.000683	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.00014	0.000683	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00014	0.00068	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00014	0.00068	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000139	0.000676	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000139	0.000676	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	0.000139	0.000675	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000139	0.000675	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000139	0.000675	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	0.000139	0.000675	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000138	0.000671	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000137	0.000666	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000137	0.000666	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000136	0.000661	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000134	0.000653	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000133	0.000649	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000133	0.000649	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000132	0.00064	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000131	0.000639	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000131	0.000639	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.00013	0.000631	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.00013	0.000631	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000127	0.00062	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000127	0.00062	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000124	0.000602	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000124	0.000602	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	0.000121	0.000589	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00012	0.000583	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00012	0.000583	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00012	0.000583	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00012	0.000583	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	0.000117	0.00057	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	0.000117	0.00057	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ALB—acquired immunodeficiency syndrome	0.000112	0.000546	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.41e-05	0.000458	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.27e-05	0.000451	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.11e-05	0.000443	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.11e-05	0.000443	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.97e-05	0.000437	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.97e-05	0.000437	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	8.53e-05	0.000415	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.48e-05	0.000413	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.3e-05	0.000404	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	8.25e-05	0.000402	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	8.25e-05	0.000402	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	8.24e-05	0.000401	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.2e-05	0.000399	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.2e-05	0.000399	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.02e-05	0.00039	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.02e-05	0.00039	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	7.97e-05	0.000388	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	7.97e-05	0.000388	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.65e-05	0.000372	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	7.61e-05	0.00037	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	7.58e-05	0.000369	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.4e-05	0.00036	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.4e-05	0.00036	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	7.36e-05	0.000358	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	7.36e-05	0.000358	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	7.33e-05	0.000357	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	7.33e-05	0.000357	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	7.23e-05	0.000352	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	6.99e-05	0.00034	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	6.99e-05	0.00034	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.9e-05	0.000238	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.88e-05	0.000237	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.74e-05	0.000231	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.74e-05	0.000231	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.72e-05	0.00023	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.72e-05	0.00023	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	4.45e-05	0.000217	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	4.31e-05	0.00021	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	4.31e-05	0.00021	CbGpPWpGaD
Cinchocaine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	4.11e-05	0.0002	CbGpPWpGaD
Cinchocaine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	3.98e-05	0.000194	CbGpPWpGaD
Cinchocaine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	3.98e-05	0.000194	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-05	0.00014	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.79e-05	0.000136	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.79e-05	0.000136	CbGpPWpGaD
